Login / Signup

Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential.

Daniel LeeInga M AntonsdottirEmily D ClarkAnton P Porsteinsson
Published in: Expert opinion on pharmacotherapy (2024)
Valiltramiprosate's clinical trial data show early indications of efficacy with potential disease modifying effect in AD.
Keyphrases
  • small molecule
  • clinical trial
  • human health
  • randomized controlled trial
  • study protocol
  • open label
  • protein protein
  • double blind
  • artificial intelligence